アフリベルセプトベータ (遺伝子組換え) (JAN);
Aflibercept beta (genetical recombination) (JAN)

SDTGRPFVEM YSEIPEIIHM TEGRELVIPC RVTSPNITVT LKKFPLDTLI PDGKRIIWDS
RKGFIISNAT YKEIGLLTCE ATVNGHLYKT NYLTHRQTNT IIDVVLSPSH GIELSVGEKL
VLNCTARTEL NVGIDFNWEY PSSKHQHKKL VNRDLKTQSG SEMKKFLSTL TIDGVTRSDQ
GLYTCAASSG LMTKKNSTFV RVHEKDKTHT CPPCPAPELL GGPSVFLFPP KPKDTLMISR
TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN
GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR DELTKNQVSL TCLVKGFYPS
DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC SVMHEALHNH
YTQKSLSLSP GK
(Disulfide bridge: 30-79, 124-185, 246-306, 352-410, 211-211', 214-214')

抗悪性腫瘍薬, 血管新生阻害薬, VEGF阻害薬

遺伝子組換え融合糖タンパク質

VEGFA [HSA:7422] [KO:K05448]
VEGFB [HSA:7423] [KO:K16858]
PGF [HSA:5228] [KO:K16859]

DDI search